» Authors » Volker Eulenburg

Volker Eulenburg

Explore the profile of Volker Eulenburg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 1513
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalinichenko L, Zoicas I, Bienia A, Buhner C, Robinson J, Kutemeyer J, et al.
Neurobiol Dis . 2025 Jan; 206:106800. PMID: 39827967
Addiction is a chronic and severe mental disorder with high gender- and sex-specificity. However, the pathogenesis of this disorder is not fully elucidated, and no targeted pharmacotherapy is available. A...
2.
Sander M, Eulenburg V, Maeyashiki T, Jang J, Muller S, Stehr S, et al.
Transplant Proc . 2024 Oct; 56(9):2046-2053. PMID: 39448275
Background: Remote organ dysfunction is common after lung transplantation and might negatively affect the outcome. The local anesthetic ropivacaine was previously demonstrated to attenuate acute rejection after allogeneic lung transplantation...
3.
Kalinichenko L, Kohl Z, Muhle C, Hassan Z, Hahn A, Schmitt E, et al.
J Neurochem . 2024 Jan; 168(3):269-287. PMID: 38284431
Point mutations in the α-synuclein coding gene may lead to the development of Parkinson's disease (PD). PD is often accompanied by other psychiatric conditions, such as anxiety, depression, and drug...
4.
Peng X, Wang J, Li Z, Jia X, Zhang A, Ju J, et al.
Neurochem Res . 2023 Aug; 48(12):3597-3609. PMID: 37561258
Background And Purpose: Morphine is amongst the most effective analgesics available for the management of severe pain. However, prolonged morphine treatment leads to analgesic tolerance which limits its clinical usage....
5.
Ziganshyna S, Szczepankiewicz G, Kuehnert M, Schulze A, Liebert U, Pietsch C, et al.
Viruses . 2022 Jun; 14(6). PMID: 35746772
Despite available vaccines, antibodies and antiviral agents, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic still continues to cause severe disease and death. Current treatment options are limited, and emerging...
6.
Lehnig M, Glass S, Lippmann N, Ziganshyna S, Eulenburg V, Werdehausen R
Microorganisms . 2022 May; 10(5). PMID: 35630394
Antimicrobial resistance belongs to the most demanding medical challenges, and antimicrobial photodynamic inactivation (aPDI) is considered a promising alternative to classical antibiotics. However, the pharmacologic characterization of novel compounds suitable...
7.
Schulz S, Ziganshyna S, Lippmann N, Glass S, Eulenburg V, Habermann N, et al.
Microorganisms . 2022 May; 10(5). PMID: 35630304
Porphyrinoid-based photodynamic inactivation (PDI) provides a promising approach to treating multidrug-resistant infections. However, available agents for PDI still have optimization potential with regard to effectiveness, toxicology, chemical stability, and solubility....
8.
Groemer T, Triller A, Zeilhofer H, Becker K, Eulenburg V, Becker C
Front Mol Neurosci . 2022 May; 15:832490. PMID: 35548669
Glycine receptors (GlyRs) are the primary mediators of fast inhibitory transmission in the mammalian spinal cord, where they modulate sensory and motor signaling. Mutations in GlyR genes as well as...
9.
Glass S, Kuhnert M, Lippmann N, Zimmer J, Werdehausen R, Abel B, et al.
RSC Adv . 2022 Apr; 11(13):7600-7609. PMID: 35423227
Photodynamic treatment is a promising tool for the therapy of multidrug-resistant bacteria. In this study, we highlight photosensitizer-loaded hydrogels as an application system for infected wounds. The poly(ethylene glycol) diacrylate-based...
10.
Kalinichenko L, Muhle C, Jia T, Anderheiden F, Datz M, Eberle A, et al.
Cereb Cortex . 2022 Mar; 33(3):844-864. PMID: 35296883
Alcohol use, abuse, and addiction, and resulting health hazards are highly sex-dependent with unknown mechanisms. Previously, strong links between the SMPD3 gene and its coded protein neutral sphingomyelinase 2 (NSM)...